Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02031094
Other study ID # 13/SS/0019
Secondary ID 2013/R/END/01
Status Completed
Phase N/A
First received November 21, 2013
Last updated October 15, 2014
Start date January 2014
Est. completion date September 2014

Study information

Verified date October 2014
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority United Kingdom: NHS Lothian/University of Edinburgh
Study type Observational

Clinical Trial Summary

This observational study will measure resting energy expenditure in patients who have undergone liver resection and compare methods of measuring resting energy expenditure.


Description:

Penetrating liver injury occurs commonly in victims of battlefield trauma. It is associated with a high mortality and morbidity rate. Management of liver injury is complex and challenging and can often involve debridement or anatomical resection of liver tissue.

Following liver resection, the liver regenerates to its original volume. Liver regeneration involves complex metabolic processes and maximal regeneration occurs over the first post operative week. This process is highly energy dependent and adds a further burden on post operative energy and therefore nutritional requirements.

Inadequate post-operative nutrition is associated with poorer outcomes and complication rates. Additionally, over feeding is also associated with adverse outcome. The actual additional energy expenditure involved in liver regeneration is not currently known and therefore accurate calorific balance remains a challenge.

The measurement of energy expenditure in these patients is therefore important. Traditionally energy expenditure has been measured by indirect calorimetry and doubly labelled water. These techniques require skilled operators and are often impractical for everyday clinical usage and impossible in the deployed setting.

A recent development is a lightweight armband that measures total and resting energy expenditure. It has been validated against the gold standard techniques in various settings including cancer cachexia, obesity and healthy volunteers and is deemed highly acceptable also. It has not been validated in the unique setting of liver regeneration.

Therefore this study will assess the energy expenditure in patients undergoing liver regeneration and attempt to validate a new minimally invasive device against the traditional measurements of energy expenditure.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

• Patients undergoing liver resection for benign or malignant hepatic neoplasm

Exclusion Criteria:

- Inability to give written, informed consent.

- Jaundice (Bilirubin > 100 µmol/L)

- Liver resection combined with secondary surgical procedure.

- Age < 18 years

- Pregnant women

- Unable to tolerate either measuring device

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Observational study: Sense Wear armband and indirect calorimetry used to measure resting energy expenditure
Observational methods of measuring resting energy expenditure

Locations

Country Name City State
United Kingdom Royal Infirmary of Edinburgh Edinburgh Lothian

Sponsors (2)

Lead Sponsor Collaborator
University of Edinburgh Royal College of Surgeons of Edinburgh

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Volume of liver resected (g) Post operative day 1 No
Other Resting energy expenditure (REE) (Kcal) 4 weeks post-operative No
Other Post-operative blood tests (FBC, U&E, LFT, Coag) Post-operative days 1-7 No
Other Complications Day of surgery and post-operative days 1-30 No
Primary Change in Resting Energy Expenditure (Kcal) following liver resection 2 weeks pre-operatively and post-operative days 3,5 and 7 No
Secondary Change in total energy expenditure (Kcal) following liver resection 2 weeks pre-operatively and post-operative days 3,5 and 7 No
See also
  Status Clinical Trial Phase
Completed NCT01960049 - Novel Technique of Analgesia Following Open Liver Resection Phase 4
Terminated NCT01921985 - Terlipressin Administration in Patients Undergoing Major Liver Resection Phase 2
Completed NCT01858987 - Stapler vs. LigaSure in Elective Hepatic Resection N/A
Completed NCT02834338 - Enhanced Perioperative Mobilization (EPM) Trial N/A
Completed NCT02216773 - Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) N/A
Recruiting NCT01355887 - A Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure Phase 3
Completed NCT02056028 - Bile Leak After Liver Surgery N/A
Recruiting NCT03917017 - The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma N/A
Active, not recruiting NCT03904667 - Application of Watson for Oncology in Hepatocellular Carcinoma Surgery
Recruiting NCT03811704 - Real-time Navigation for Laparoscope Liver Resections Using Fusion 3D Imaging and Indocyanine Green Fluorescence Imaging Phase 2
Completed NCT03171428 - Hepatectomy With or Without the Thoraco-abdominal Approach N/A
Completed NCT01770041 - Paracetamol Metabolism After Liver Surgery N/A
Recruiting NCT04692259 - May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI N/A
Active, not recruiting NCT03600168 - Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery
Recruiting NCT04889235 - Diaphragm Kinetics Following Hepatic Resection